Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07186842 · ClinicalTrials.gov registry record · Phase 1
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
A Phase 1 study of Advanced Solid Cancers, sponsored by BioNTech SE.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 245
- Enrollment target
- 4
- Study locations
NCT07186842 is a Phase 1 study of Advanced Solid Cancers that is actively recruiting participants, run by BioNTech SE. The registered enrollment target is 245 participants. The trial reports 4 study locations across 2 states.
The verdict
NCT07186842, a Phase 1 study of Advanced Solid Cancers, is actively recruiting participants, sponsored by BioNTech SE.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 245 participants
- Enrollment target
- 4
- Study locations
Study Summary
The main goal of this study is to evaluate the safety of BNT329 and to identify the best dose of BNT329. This will be done by measuring the number of side effects that participants experience and how severe they are. The second goal of this study is to evaluate how well BNT329 works. This will be done by measuring the number of participants who respond to the treatment. The length of time where the tumor does not grow or spread will also be measured. The study will also evaluate how BNT329 moves into, through, and out of the body and how the treatment affects the body.
Conditions Studied
Interventions
- DRUG BNT329
- DRUG CA19-9-targeting monoclonal antibody
Study Locations (4)
Other
- Hospital Universitario HM Sanchinarro - START Madrid CIOCC - Madrid
- Hospital Universitario Quironsalud Madrid - NEXT Oncology - Pozuelo de Alarcón
- The Royal Marsden Hospital - Sutton
Florida
- Florida Cancer Specialists - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2025-11-18 |
| Est. Completion | 2030-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07186842
The ClinicalTrials.gov registry entry for NCT07186842 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioNTech SE, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Advanced Solid Cancers appearing as the primary indexed condition, and to 2 interventions - of which BNT329 is the first listed.
NCT07186842 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Other, Florida.
Frequently Asked Questions
What is clinical trial NCT07186842 about?
NCT07186842 is a clinical study titled "A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9". The main goal of this study is to evaluate the safety of BNT329 and to identify the best dose of BNT329. This will be done by measuring the number of side effects that participants experience and how severe they are. The second goal of this study is to evaluate how well BNT329 works. This will be d...
What is the current status of trial NCT07186842?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 245 participants. The study started on 2025-11-18. Estimated completion is 2030-05.
What conditions does trial NCT07186842 study?
This clinical trial studies the following conditions: Advanced Solid Cancers.
What interventions are being tested in trial NCT07186842?
The interventions under investigation include: BNT329 (DRUG), CA19-9-targeting monoclonal antibody (DRUG).
Who is sponsoring clinical trial NCT07186842?
This trial is sponsored by BioNTech SE, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07186842 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Solid Cancers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.